Literature DB >> 26638867

Direct Evidence of Internalization of Tau by Microglia In Vitro and In Vivo.

Marta Bolós1,2, María Llorens-Martín1,2, Jerónimo Jurado-Arjona1,2, Félix Hernández1,2, Alberto Rábano3, Jesús Avila1,2.   

Abstract

The microtubule-associated protein (MAP) tau plays a critical role in the pathogenesis of tauopathies. Excess tau can be released into the extracellular medium in a physiological or pathological manner to be internalized by surrounding neurons-a process that contributes to the spread of this protein throughout the brain. Such spreading may correlate with the progression of the abovementioned diseases. In addition to neurons, tau can be internalized into other cells. Here we demonstrate that microglia take up tau in vitro and in vivo. In this regard, microglia from primary cultures internalized soluble (human recombinant tau42) and insoluble (homogenates derived from human AD brain) tau in vitro. Furthermore, using stereotaxic injection of tau in mice in vivo, we show that murine microglia internalize human tau. In addition, we demonstrate, for the first time, that microglia colocalize with various forms of tau in postmortem brain tissue of patients with Alzheimer's disease and non-demented control subjects. Our data reveal a potential role of microglia in the internalization of tau that might be relevant for the design of strategies to enhance the clearance of extracellular tau in neurodegenerative diseases characterized by the accumulation of this protein.

Entities:  

Keywords:  Alzheimer’s disease; clearance; microglia; tau protein; tauopathies

Mesh:

Substances:

Year:  2016        PMID: 26638867     DOI: 10.3233/JAD-150704

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  69 in total

Review 1.  Microglial priming in Alzheimer's disease.

Authors:  Jun-Wei Li; Yu Zong; Xi-Peng Cao; Lin Tan; Lan Tan
Journal:  Ann Transl Med       Date:  2018-05

Review 2.  Clearance of Amyloid Beta and Tau in Alzheimer's Disease: from Mechanisms to Therapy.

Authors:  Shu-Hui Xin; Lin Tan; Xipeng Cao; Jin-Tai Yu; Lan Tan
Journal:  Neurotox Res       Date:  2018-04-07       Impact factor: 3.911

Review 3.  The complexity of tau in Alzheimer's disease.

Authors:  Nima N Naseri; Hong Wang; Jennifer Guo; Manu Sharma; Wenjie Luo
Journal:  Neurosci Lett       Date:  2019-04-25       Impact factor: 3.046

4.  Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer's Disease.

Authors:  Alexandra Litvinchuk; Ying-Wooi Wan; Dan B Swartzlander; Fading Chen; Allysa Cole; Nicholas E Propson; Qian Wang; Bin Zhang; Zhandong Liu; Hui Zheng
Journal:  Neuron       Date:  2018-11-08       Impact factor: 17.173

5.  Reduced gliotransmitter release from astrocytes mediates tau-induced synaptic dysfunction in cultured hippocampal neurons.

Authors:  Roberto Piacentini; Domenica Donatella Li Puma; Marco Mainardi; Giacomo Lazzarino; Barbara Tavazzi; Ottavio Arancio; Claudio Grassi
Journal:  Glia       Date:  2017-05-18       Impact factor: 7.452

Review 6.  Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight.

Authors:  Yang Shi; David M Holtzman
Journal:  Nat Rev Immunol       Date:  2018-12       Impact factor: 53.106

Review 7.  Synergy between amyloid-β and tau in Alzheimer's disease.

Authors:  Marc Aurel Busche; Bradley T Hyman
Journal:  Nat Neurosci       Date:  2020-08-10       Impact factor: 24.884

8.  Tau Misfolding Efficiently Propagates between Individual Intact Hippocampal Neurons.

Authors:  Grace I Hallinan; Mariana Vargas-Caballero; Jonathan West; Katrin Deinhardt
Journal:  J Neurosci       Date:  2019-10-28       Impact factor: 6.167

Review 9.  Microglia in neurodegeneration.

Authors:  Suzanne Hickman; Saef Izzy; Pritha Sen; Liza Morsett; Joseph El Khoury
Journal:  Nat Neurosci       Date:  2018-09-26       Impact factor: 24.884

Review 10.  Cell-to-Cell Transmission of Tau and α-Synuclein.

Authors:  Norihito Uemura; Maiko T Uemura; Kelvin C Luk; Virginia M-Y Lee; John Q Trojanowski
Journal:  Trends Mol Med       Date:  2020-05-01       Impact factor: 11.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.